GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

1,679.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 1,722.50
  • 52 Week Low: 1,387.50
  • Currency: UK Pounds
  • Shares Issued: 4,916.92m
  • Volume: 9,630,529
  • Market Cap: 82,555m
  • RiskGrade: 52
  • Beta: 0.54

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 4.8% 4.8%
Div Cover 1.3 1.4
Op Mrgn 9.3% 25.5%
ROCE 162.9%  
Latest F'cast
P/E 16.4 15.1
PEG 0.5 1.8
Pr/Revenue 3.0 2.8
Pr/Book 16.6  
Latest F'cast
Revenue 16.6% 7.4%
PBT -81.6% 294.2%
EPS 35.3% 8.2%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 26,431.00 6,600.00 111.40p 12.0 n/a -2% 74.00p 5.5%
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 29,962.74 7,644.46 110.82p 15.2 1.8 +8% 80.00p 4.8%
31-Dec-18 31,073.88 8,073.16 114.39p 14.7 4.6 +3% 80.28p 4.8%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Notice of AGM 30-Mar-2017 13:00 RNS
Director/PDMR Shareholding 23-Mar-2017 16:55 RNS
Director/PDMR Shareholding 21-Mar-2017 12:19 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
22-Mar-17 Buy Moncef Slaoui 1,693.98p 8 135.52
15-Mar-17 Buy Moncef Slaoui 1,708.92p 182 3,110.22
15-Mar-17 Buy Moncef Slaoui 1,708.92p 8 136.71

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,679.00p
Change Today 0.50p
% Change 0.03 %
52 Week High 1,722.50
52 Week Low 1,387.50
Volume 9,630,529
Shares Issued 4,916.92m
Market Cap 82,555m
Beta 0.54
RiskGrade 52

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.12% below the market average5.12% below the market average5.12% below the market average5.12% below the market average5.12% below the market average
93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average
Price Trend
23.48% above the market average23.48% above the market average23.48% above the market average23.48% above the market average23.48% above the market average
34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average
Income
69.36% above the market average69.36% above the market average69.36% above the market average69.36% above the market average69.36% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
9.71% above the market average9.71% above the market average9.71% above the market average9.71% above the market average9.71% above the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average

What The Brokers Say

Strong Buy 14
Buy 1
Neutral 12
Sell 0
Strong Sell 3
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-17 03-Nov-16
Paid 13-Apr-17 12-Jan-17
Amount 23.00p 19.00p

Trades for 30-Mar-2017

Time Volume / Share Price
17:10 2,940 @ 1,678.85p
17:03 6,768 @ 1,678.23p
17:03 7,512 @ 1,683.49p
17:01 40,517 @ 1,684.22p
17:01 43,103 @ 1,684.22p

GlaxoSmithKline Key Personnel

CEO Sir Andrew P Witty
Chair Moncef Slaoui
CFO Simon Dingemans

Top of Page